Modeling Alzheimer's disease in transgenic rats

Area of Science:

• Neuroscience
• Genetics
• Pharmacology

Background:

• Alzheimer's disease (AD) is the most prevalent form of dementia, characterized by amyloid plaques, neurofibrillary tangles, and neuronal loss.
• Current treatments are ineffective as diagnosis often occurs after irreversible brain damage, highlighting the need to understand preclinical AD stages.

Purpose of the Study:

• To summarize efforts in creating transgenic rat models that mimic Alzheimer's disease (AD) pathology.
• To highlight the advantages of rat models over mouse models for studying preclinical AD and evaluating therapeutics.

Main Methods:

• Development of transgenic rat models exhibiting key pathological features of AD.
• Comparative analysis of physiological, genetic, and morphological similarities between rats and humans.

Main Results:

• Transgenic rat models provide a valuable tool for investigating the mechanisms of preclinical AD.
• Rats offer advantages due to their closer resemblance to humans and complex behavioral repertoire.

Conclusions:

• Rat models of AD facilitate more accurate assessment of pathology and therapeutic efficacy on cognitive functions.
• These models are crucial for identifying and validating new therapeutic targets during the early, preclinical stages of Alzheimer's disease.